1 Min Read
Feb 13 (Reuters) - Bioverativ Inc:
* BIOVERATIV REPORTS FOURTH QUARTER AND FULL YEAR 2017 PERFORMANCE
* QTRLY ‍SHR $1.30​ Source text for Eikon: Further company coverage: